Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01185574 · ClinicalTrials.gov registry record · NA

Vitamin D for Improving Metabolic Control and Depressive Symptoms

A NA study of Diabetes and Depressive Symptoms, sponsored by Loyola University.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT01185574 is a NA study of Diabetes and Depressive Symptoms that has completed, run by Loyola University. The registered enrollment target is 50 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01185574, a NA study of Diabetes and Depressive Symptoms, has completed, sponsored by Loyola University.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study will examine whether weekly vitamin D supplementation in women with significant depressive symptoms and diabetes will exhibit improved mood and metabolic control. If supplementation with Vitamin D is beneficial, it will be a simple and cost-effective method for treatment. Women will be targeted since they have greater depression and worse metabolic control than men with diabetes.

Interventions

  • DIETARY_SUPPLEMENT Vitamin D supplementation

Study Locations (1)

Illinois

  • Loyola University Medical Center - Maywood

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2009-10
Est. Completion 2012-05
Phase NA

Sponsor

Loyola University

92 total trials

What the Registry Record Tells You About NCT01185574

The ClinicalTrials.gov registry entry for NCT01185574 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Vitamin D supplementation is the first listed.

NCT01185574 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT01185574 about?

NCT01185574 is a clinical study titled "Vitamin D for Improving Metabolic Control and Depressive Symptoms". This study will examine whether weekly vitamin D supplementation in women with significant depressive symptoms and diabetes will exhibit improved mood and metabolic control. If supplementation with Vitamin D is beneficial, it will be a simple and cost-effective method for treatment. Women will be ta...

What is the current status of trial NCT01185574?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2009-10. Estimated completion is 2012-05.

What conditions does trial NCT01185574 study?

This clinical trial studies the following conditions: Diabetes, Depressive Symptoms.

What interventions are being tested in trial NCT01185574?

The interventions under investigation include: Vitamin D supplementation (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01185574?

This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01185574 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.